Life Science Nord’s Post

🇰🇷🩺 Would you like to take part in the Healthcare and Medical Equipment Korea 2025 business mission? Deadline extended - apply before 15 November! 🚀 Thanks to Healthcare and Medical Equipment Korea 2025, 50 European SMEs including start-ups will visit the Republic of Korea and kick-start their internationalisation path in the Healthcare and Medical Equipment sector. Target audience: 🔹European SMEs including start-ups and South Korean enterprises involved in the Healthcare and Medical Equipment sector, such as: Assistive technologies, Medical equipment, ICT for healthcare, Telemedicine and remote health monitoring, Nanotechnology in healthcare, AI applications in healthcare, Regenerative Medicine and Tissue Engineering. 🔹South Korean Business Operators, notably buyers, distributors and R&D partners in public and private sectors, and investors. ✨ This business mission presents a unique opportunity for EU SMEs to establish valuable contacts, showcase their solutions, build long-lasting relationships with Korean enterprises and explore new business avenues together. The EU Business Hub provides market insights, matchmaking services, financial and tailored support to companies. Learn more and apply now: https://lnkd.in/daZ4cTCF

Your Gateway to Southeast Asian Markets: Partner with Arazy Group for Seamless MedTech Registrations 🌏 For nearly 30 years, Arazy Group has been transforming the MedTech landscape, empowering companies to fast-track their regulatory approvals. We simplify the process so you can focus on innovation, while we ensure your product reaches key markets across Southeast Asia. Pioneers like Sinclair, RAPID AI, and Apyx Medical, Circle Cardio Vascular and Butterfly trust us for swift registrations in dynamic regions. Are you ready to expand into Southeast Asia? Let’s unlock new opportunities together! https://hubs.ly/Q02NRZxc0 🌟 Where Next? Explore limitless potential with Arazy Group through our Global IVDs & Medical Device Registration and Market-Access Platform. hashtag #MedTechSoutheastAsia hashtag #RegulatoryInnovation hashtag #ProductExpansion hashtag #ASEANMarketAccess hashtag #HealthcareTransformation hashtag #RegulatoryComplianceSEA hashtag #MedDeviceRegistration hashtag #EmergingMarketsMedTech hashtag #SoutheastAsiaHealthcare hashtag #MedTechExpansion hashtag #RegulatoryExcellenceSEA hashtag #ArazyGroup

Your Gateway to Southeast Asian Markets: Partner with Arazy Group for Seamless MedTech Registrations 🌏 For nearly 30 years, Arazy Group has been transforming the MedTech landscape, empowering companies to fast-track their regulatory approvals. We simplify the process so you can focus on innovation, while we ensure your product reaches key markets across Southeast Asia. Pioneers like Sinclair, RAPID AI, and Apyx Medical, Circle Cardio Vascular and Butterfly trust us for swift registrations in dynamic regions. Are you ready to expand into Southeast Asia? Let’s unlock new opportunities together! https://hubs.ly/Q02NRZxc0 🌟 Where Next? Explore limitless potential with Arazy Group through our Global IVDs & Medical Device Registration and Market-Access Platform. #MedTechSoutheastAsia #RegulatoryInnovation #ProductExpansion #ASEANMarketAccess #HealthcareTransformation #RegulatoryComplianceSEA #MedDeviceRegistration #EmergingMarketsMedTech #SoutheastAsiaHealthcare #MedTechExpansion #RegulatoryExcellenceSEA #ArazyGroup

Friends, Did you know that Japan ranks as the third-largest medical and healthcare market globally, following the USA and China in terms of expenditure, US$ 472672 Million. It is almost 1.8 times the Indian expenditures figures of US$ 268809 Million. In my discussions with Indian medical and healthcare industry manufacturers and exporters, I've often encountered concerns about Japan being a challenging market for exports due to its stringent regulations, even tougher than those of the US FDA. However, amidst these challenges, there's an exciting opportunity brewing. Many are contemplating participation in MEDICAL JAPAN メディカルジャパン（ 医療・介護・薬局Week）, slated for October 9th to October 11th in Tokyo, Japan. Some are considering this platform to explore becoming OEM or contract manufacturers for Japanese companies. Others are keen on finding agents and distributors not only in Japan but also among the 19 other visitor/buyer countries represented at MEDICAL JAPAN メディカルジャパン（ 医療・介護・薬局Week） This event isn't just a trade show; it's a gateway to unprecedented opportunities in one of the world's most dynamic healthcare markets. If you're ready to unlock the potential of the Japanese medical and healthcare sector, I invite you to reach out. Let's explore how your company can thrive in Japan's thriving healthcare landscape. Siddharth Bhaiya, CFA Association of Indian Medical Device Industry (AIMED) Kazuhito Maruyama Rajiv Nath Shalya Medical Technologies (India) Pvt. Ltd. Shalya SI Surgical Pvt Ltd Dolphin Sutures Advanced Medical Solutions Advanced Medical Solutions - Surgical Healthium Medtech Limited Welmed

Your Gateway to Southeast Asian Markets: Partner with Arazy Group for Seamless MedTech Registrations 🌏 For nearly 30 years, Arazy Group has been transforming the MedTech landscape, empowering companies to fast-track their regulatory approvals. We simplify the process so you can focus on innovation, while we ensure your product reaches key markets across Southeast Asia. Pioneers like Sinclair, RAPID AI, and Apyx Medical, Circle Cardio Vascular and Butterfly trust us for swift registrations in dynamic regions. Are you ready to expand into Southeast Asia? Let’s unlock new opportunities together! https://hubs.ly/Q02NRTYK0 🌟 Where Next? Explore limitless potential with Arazy Group through our Global IVDs & Medical Device Registration and Market-Access Platform. #MedTechSoutheastAsia #RegulatoryInnovation #ProductExpansion #ASEANMarketAccess #HealthcareTransformation #RegulatoryComplianceSEA #MedDeviceRegistration #EmergingMarketsMedTech #SoutheastAsiaHealthcare #MedTechExpansion #RegulatoryExcellenceSEA #ArazyGroup

The NMPA's Center for Medical Device Evaluation recently released a second draft of the "Guidance Principles for the Registration review of Human Factors Design in Medical Devices" for public review. PDD is a founding executive member of the Human Factors Special Committee and has been promoting HFE principles in China since 2015. From our studio in Shanghai, we partner with global healthcare clients to develop solutions that meet the needs of patients and HCPs in China and Asia. Our work ranges from wearable and handheld drug delivery devices to diagnostics, monitoring and large-scale imaging equipment. This article outlines how the latest draft will impact companies looking to enter or expand in China and how integrating HFE early in the development process, can future-proof their business in this competitive, rapidly evolving market. If you would like to learn more get in touch with Vicky Hong who would be happy to answer any questions you may have. You can read the full article here 👉 https://lnkd.in/gkBYxKQp #NMPA #humanfactors #medicaldevices #healthcareinnovation #drugdelivery #diagnostics #china

Over the past two weeks I have attended a couple of MedTech conferences in Singapore, namely the Medical Fair Asia and MedTech World Singapore. Having an interest in technologies that make lives easier/better, learning more about issues within this space has been nothing short of inspirational. In the midst of hearing about regulatory nuances for MedTech companies, GenAI for healthcare, and medical device distribution+commercialisation models, I was struck by how interesting it is to have an outsiders perspective on any industry. Add the fun, stimulating conversations with industry professionals, and you arrive at an insightful learning environment. Hoping to learn more about the world as I go along! #medtech #innovation #GenAI4Pharma

Congratulations to Jiangxi Rimag Group Co.,Ltd. (2522.HK) on its successful Listing on the Mainboard of HKSE on 7 June 2024. Jiangxi Rimag Group Co.,Ltd. (“Rimag”) , a prominent medical group in China specializing in medical imaging, is the sole operator and manager of a comprehensive medical imaging platform offering diverse services and value across the entire industry chain in China. Rimag mainly compete in the PRC third-party medical imaging center market, a fast-growing segment whose market size grew at a CAGR of 29.0% from 2018 to 2023 and is expected to grow with a CAGR of 33.5% from 2023 to 2026, far exceeding that of 12.9% and 14.3% of the PRC medical imaging service market during the same periods, respectively. With regard to this listing application, AVISTA Group is honoured to be engaged in providing valuation services in relation to preferred shares, employee stock plan, M&A transactions, financial assets, goodwill and asset impairment tests and expected credit losses.

🗣️Today, at the opening of the World Intellectual Property Organization – WIPO Global Challenge Seminar on Driving Med Tech Innovation Ecosystems in the least developed countries, Mr Edward Kwakwa, Assistant Director General, WIPO & Ms Federica Falomi, Economic Affairs Officer, UN Technology Bank for Least Developed Countries, highlighted the importance & lack of essential medical technology for #NCDs as a crucial issue. 📌According to them, only 19% of people in LMICs have access to diagnostics ⏰It's time to #LeadOnNCDs & ensure access to affordable quality NCD care for everyone everywhere.

50 years of advancing healthcare, Redefining the next 50 years in Singapore!